3rtp
From Proteopedia
Contents |
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration
Template:ABSTRACT PUBMED 21813278
Disease
[MK10_HUMAN] Defects in MAPK10 are a cause of epileptic encephalopathy Lennox-Gastaut type (EELG) [MIM:606369]. Epileptic encephalopathies of the Lennox-Gastaut group are childhood epileptic disorders characterized by severe psychomotor delay and seizures. Note=A chromosomal aberration involving MAPK10 has been found in a single patient. Translocation t(Y;4)(q11.2;q21) which causes MAPK10 truncation.
Function
[MK10_HUMAN] Serine/threonine-protein kinase involved in various processes such as neuronal proliferation, differentiation, migration and programmed cell death. Extracellular stimuli such as proinflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK10/JNK3. In turn, MAPK10/JNK3 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity. Plays regulatory roles in the signaling pathways during neuronal apoptosis. Phosphorylates the neuronal microtubule regulator STMN2. Acts in the regulation of the beta-amyloid precursor protein/APP signaling during neuronal differentiation by phosphorylating APP. Participates also in neurite growth in spiral ganglion neurons.[1]
About this Structure
3rtp is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- ↑ Neidhart S, Antonsson B, Gillieron C, Vilbois F, Grenningloh G, Arkinstall S. c-Jun N-terminal kinase-3 (JNK3)/stress-activated protein kinase-beta (SAPKbeta) binds and phosphorylates the neuronal microtubule regulator SCG10. FEBS Lett. 2001 Nov 16;508(2):259-64. PMID:11718727
Categories: Homo sapiens | Mitogen-activated protein kinase | Artis, D R. | Bard, F. | Bowers, S. | Chan, W. | Chen, L. | Dryer, M. | Galemmo, R A. | Goldbach, E. | Griswold-Prenne, I. | Hom, R K. | Konradi, A W. | Lin, M. | Lorentzen, C. | Neitz, R J. | Pan, H. | Peterson, B. | Powell, K. | Probst, G D. | Quincy, Q. | Quinn, K P. | Ren, Z. | Ruslim, L. | Samant, B. | Sauer, J. | Sealy, J M. | Sham, H L. | Tonn, G. | Truong, A P. | Wong, K. | Wright, S. | Yao, N. | Yednock, T A. | Zhang, H. | Zmolek, W. | Jnk inhibitor | Neurodegeneration | Pharmacokinetic property | Transferase-transferase inhibitor complex